ABP-7 Peptide (10mg)
ABP-7 10 mg provides a high-purity, laboratory-verified lyophilized peptide manufactured under strict quality control standards in the USA. Formulated with 10 mg of pure ABP-7 per vial, this product undergoes rigorous third-party analytical testing to confirm optimal sequence integrity and purity exceeding 99%. ABP-7 is utilized in advanced biological and biochemical research models investigating cellular signaling pathways, protein interaction kinetics, and tissue-specific receptor dynamics.
Key Specifications
Ā Active Compound: ABP-7
Ā Concentration: 10 mg per vial
Ā Purity Standard: Exceeds 99% (Third-Party HPLC & Mass Spectrometry Verified)
Ā Formulation: Sterile Lyophilized Powder
Ā Origin: Manufactured in USA
Ā Classification: Research Use Only
Primary Research Applications
Ā Cellular Signaling & Receptor Interactions: Utilized in in-vitro models to study ligand-receptor binding affinity, intracellular cascade activation, and cell membrane interaction dynamics.
Ā Biochemical & Molecular Analysis: Engineered for laboratory assays requiring high structural stability, consistent molecular weight verification, and minimal lot-to-lot variability.
Ā Tissue & Metabolic Dynamics: Investigated in specialized cellular protocols focusing on protein synthesis pathways and targeted cellular response mechanisms.
BPC-157 & TB-500 & GHK-Cu Blend (70mg)
BPC-157 / TB-500 / GHK-Cu provides a high-purity, laboratory-verified lyophilized multi-peptide blend manufactured under strict quality control standards in the USA. Formulated as an advanced triple-action tissue regeneration complex, each vial combines 10 mg of BPC-157 (Body Protection Compound-157), 10 mg of TB-500 (Thymosin Beta-4 fragment), and 50 mg of GHK-Cu (Copper Tripeptide-1). This synergistic 70 mg total blend is widely utilized in orthopedic, dermatological, and cellular repair research examining angiogenesis, actin sequestration, collagen remodeling, and wound healing cascades.
Key Specifications
Ā Active Compounds: BPC-157 (Pentadecapeptide), TB-500 (Thymosin Beta-4 Fragment), & GHK-Cu (Copper Tripeptide-1)
Ā Blend Concentration: 10 mg BPC-157 + 10 mg TB-500 + 50 mg GHK-Cu (70 mg total per vial)
Ā Chemical Formulas: \text{C}_{62}\text{H}_{98}\text{N}_{16}\text{O}_{22} (BPC-157) / \text{C}_{212}\text{H}_{350}\text{N}_{56}\text{O}_{78}\text{S} (TB-500) / \text{C}_{14}\text{H}_{24}\text{CuN}_{6}\text{O}_{4} (GHK-Cu)
Ā Purity Standard: Exceeds 99% (Third-Party HPLC Verified)
Ā Formulation: Sterile Lyophilized Powder
Ā Origin: Manufactured in USA
Ā Classification: Research Use Only
Primary Research Applications
Ā Synergistic Angiogenesis & Microvascular Repair: Combines BPC-157's VEGFR2 pathway modulation with TB-500's cell migration properties to evaluate accelerated capillary outgrowth and blood vessel formation in damaged tissues.
Ā Extracellular Matrix & Collagen Synthesis: GHK-Cu works in tandem with BPC-157 and TB-500 to stimulate Type I and III collagen expression, dermal fibroblast activation, and glycosaminoglycan production.
Ā Musculoskeletal Tissue Regeneration: Extensively studied in tendon, ligament, muscle, and fascial injury models to measure actin regulation, cell migration to damage sites, and reduced inflammatory scarring.
BPC-157 & TB-500 Blend 20mg
BPC-157 / TB-500 20mg provides a high-purity, laboratory-verified lyophilized peptide blend manufactured under strict quality control standards in the USA. Formulated as a synergistic tissue recovery complex, each vial combines BPC-157 (Body Protection Compound-157, a synthetic pentadecapeptide) with TB-500 (Thymosin Beta-4 synthetic fragment). This dual-action blend is widely utilized in orthopedic, gastrointestinal, and cellular repair research examining accelerated wound healing cascades, microvascular formation, actin regulation, and connective tissue remodeling.
Key Specifications
Ā Active Compounds: BPC-157 (Pentadecapeptide) & TB-500 (Thymosin Beta-4 Fragment)
Ā Chemical Formulas: \text{C}_{62}\text{H}_{98}\text{N}_{16}\text{O}_{22} (BPC-157) / \text{C}_{212}\text{H}_{350}\text{N}_{56}\text{O}_{78}\text{S} (TB-500)
Ā Purity Standard: Exceeds 99% (Third-Party HPLC Verified)
Ā Formulation: Sterile Lyophilized Powder
Ā Origin: Manufactured in USA
Ā Classification: Research Use Only
Primary Research Applications
Ā Angiogenesis & Microvascular Upregulation: Combines BPC-157's VEGFR2 pathway upregulation with TB-500's endothelial cell migration properties to study rapid blood vessel formation in damaged tissues.
Ā Actin Polymerization & Cell Mobility: TB-500 sequestering of G-actin works alongside BPC-157 to examine accelerated cell migration, tendon-to-bone insertion recovery, and fascial repair.
Ā Cytoprotection & Inflammation Modulation: Evaluated in cellular stress models to investigate the downregulation of pro-inflammatory cytokines and stabilization of mucosal and musculoskeletal matrices.
Melanotan 1 (10mg)
Melanotan 1 10 mg provides a high-purity, laboratory-verified lyophilized peptide manufactured under strict quality control standards in the USA. Formulated with 10 mg of pure Melanotan 1 (Melanotan I / Afamelanotide)āa synthetic linear peptide analog of endogenous alpha-melanocyte-stimulating hormone (\alpha-MSH)āthis compound is widely utilized in dermatological, photobiological, and melanocortin receptor research examining melanogenesis activation, UV photoprotection mechanisms, and receptor selectivity.
Key Specifications
Ā Active Compound: Melanotan 1 (Melanotan I / Afamelanotide)
Ā Chemical Formula: \text{C}_{78}\text{H}_{111}\text{N}_{21}\text{O}_{19}
Ā Molecular Weight: 1646.85 \text{ g/mol}
Ā Concentration: 10 mg per vial
Ā Purity Standard: Exceeds 99% (Third-Party HPLC & Mass Spectrometry Verified)
Ā Formulation: Sterile Lyophilized Powder
Ā Origin: Manufactured in USA
Ā Classification: Research Use Only
Primary Research Applications
Ā Melanocortin Receptor Binding Kinetics: Melanotan 1 acts as a non-selective agonist at melanocortin receptors (MC1R, MC3R, MC4R, MC5R), serving as a core benchmark in evaluating MC1R-mediated cAMP signaling in epidermal melanocytes.
Ā Melanogenesis & Photoprotection Models: Widely studied in cellular models investigating eumelanin synthesis, skin pigmentation pathways, and cellular defense mechanisms against ultraviolet (UV) radiation-induced DNA damage.
Ā Vascular & Anti-Inflammatory Signaling: Investigated for its role in non-pigmentary melanocortin signaling, including microvascular integrity, inflammatory response modulation, and cutaneous homeostasis.
Oxytocin Peptide (10mg)
Oxytocin 10 mg provides a high-purity, laboratory-verified lyophilized neuropeptide manufactured under strict quality control standards in the USA. Formulated with 10 mg of pure Oxytocināa nonapeptide hormone naturally synthesized in the paraventricular and supraoptic nuclei of the hypothalamusāthis compound is widely utilized in neurobiology, behavioral endocrinology, and cardiovascular research examining central oxytocinergic pathways, social bonding behavior, stress attenuation, and smooth muscle signaling.
Key Specifications
Ā Active Compound: Oxytocin
Ā Chemical Formula: \text{C}_{43}\text{H}_{66}\text{N}_{12}\text{O}_{12}\text{S}_{2}
Ā Molecular Weight: 1007.2 \text{ g/mol}
Ā Concentration: 10 mg per vial
Ā Purity Standard: Exceeds 99% (Third-Party HPLC & Mass Spectrometry Verified)
Ā Formulation: Sterile Lyophilized Powder
Ā Origin: Manufactured in USA
Ā Classification: Research Use Only
Primary Research Applications
Ā Neuroendocrine & Social Behavior Dynamics: Oxytocin acts on central oxytocin receptors (OXTR) to modulate neural circuits involved in prosocial behavior, pair-bonding, empathy, trust dynamics, and maternal behavior in animal models.
Ā HPA Axis Regulation & Anxiolysis: Widely investigated for its stress-attenuating properties, examining how OXTR activation downregulates hypothalamic-pituitary-adrenal (HPA) axis activity and blunts corticosterone/cortisol release during acute stress responses.
Ā Neuromuscular & Cardiovascular Signaling: Evaluated in peripheral tissue models to study G-protein coupled receptor (GPCR) cascades governing uterine smooth muscle contraction, myoepithelial cell signaling, and vascular endothelial nitric oxide production.
PT-141 (Bremelanotide) (10mg)
PT-141 10 mg provides a high-purity, laboratory-verified lyophilized peptide manufactured under strict quality control standards in the USA. Formulated with 10 mg of pure PT-141 (Bremelanotide)āa synthetic cyclic peptide agonist of melanocortin receptors (MC3R and MC4R)āthis compound is widely utilized in neuroendocrine, behavioral, and central nervous system (CNS) signaling research examining melanocortin pathway activation, sexual behavior dynamics, and cardiovascular safety parameters.
Key Specifications
Ā Active Compound: PT-141 (Bremelanotide)
Ā Chemical Formula: \text{C}_{50}\text{H}_{68}\text{N}_{14}\text{O}_{10}
Ā Molecular Weight: 1025.2 \text{ g/mol}
Ā Concentration: 10 mg per vial
Ā Purity Standard: Exceeds 99% (Third-Party HPLC & Mass Spectrometry Verified)
Ā Formulation: Sterile Lyophilized Powder
Ā Origin: Manufactured in USA
Ā Classification: Research Use Only
Primary Research Applications
Ā Central Melanocortin Receptor Signaling: PT-141 acts primarily as a high-affinity agonist at central melanocortin-3 (MC3R) and melanocortin-4 (MC4R) receptors in the hypothalamus, serving as a primary tool to evaluate central nervous system-mediated behavioral pathways.
Ā Neuroendocrine & Behavioral Dynamics: Extensively studied in animal models to investigate non-vascular, neurogenic mechanisms modulating sexual motivation, appetitive behavior, and dopamine release in the medial preoptic area (mPOA).
Ā Vascular & Hemodynamic Safety Studies: Evaluated in cardiovascular research models to assess systemic pressor responses and transient blood pressure/heart rate variations associated with melanocortin receptor cross-reactivity.
Sermorelin & GHRP-2 Blend (10mg)
Sermorelin 5 mg / GHRP-2 5 mg provides a high-purity, laboratory-verified lyophilized peptide blend manufactured under strict quality control standards in the USA. Formulated as a dual-action secretagogue complex, each vial combines 5 mg of Sermorelin (a synthetic 29-amino-acid analog of Growth Hormone-Releasing Hormone) with 5 mg of GHRP-2 (Growth Hormone-Releasing Peptide-2, a synthetic ghrelin receptor agonist). This blend is widely utilized in endocrinology, somatotropic axis dynamics, and metabolic research examining synergistic GH pulse amplification, pituitary somatotroph receptor interaction, and circulating IGF-1 elevation.
Key Specifications
Active Compounds: Sermorelin (GHRH 1-29) & GHRP-2 (Pralmorelin)
Blend Ratio / Concentration: 5 mg Sermorelin + 5 mg GHRP-2 (10 mg total per vial)
Chemical Formulas: \text{C}_{149}\text{H}_{246}\text{N}_{44}\text{O}_{42} (Sermorelin) / \text{C}_{45}\text{H}_{55}\text{N}_{9}\text{O}_{6} (GHRP-2)
Purity Standard: Exceeds 99% (Third-Party HPLC Verified)
Formulation: Sterile Lyophilized Powder
Origin: Manufactured in USA
Classification: Research Use Only
Primary Research Applications
Dual-Mechanism GH Secretion Synergy: Combines GHRH receptor stimulation (Sermorelin) with ghrelin/growth hormone secretagogue receptor (GHS-R) binding (GHRP-2) to analyze supra-additive pituitary growth hormone pulsatility.
Somatotropic Axis & IGF-1 Dynamics: Extensively evaluated in endocrine research models measuring downstream serum IGF-1 upregulation, nitrogen retention, and cellular protein synthesis signaling.
Metabolic Rate & Lipid Oxidation: Investigated in body composition models to assess lipolysis mechanisms, visceral fat metabolism, and recovery dynamics following cellular stress.
Sermorelin & GHRP-6 & GHRP-2 Blend (9mg)
Sermorelin 5 mg / GHRP-2 5 mg provides a high-purity, laboratory-verified lyophilized peptide blend manufactured under strict quality control standards in the USA. Formulated as a dual-action secretagogue complex, each vial combines 5 mg of Sermorelin (a synthetic 29-amino-acid analog of Growth Hormone-Releasing Hormone) with 5 mg of GHRP-2 (Growth Hormone-Releasing Peptide-2, a synthetic ghrelin receptor agonist). This blend is widely utilized in endocrinology, somatotropic axis dynamics, and metabolic research examining synergistic GH pulse amplification, pituitary somatotroph receptor interaction, and circulating IGF-1 elevation.
Key Specifications
Ā Active Compounds: Sermorelin (GHRH 1-29) & GHRP-2 (Pralmorelin)
Ā Blend Ratio / Concentration: 5 mg Sermorelin + 5 mg GHRP-2 (10 mg total per vial)
Ā Chemical Formulas: \text{C}_{149}\text{H}_{246}\text{N}_{44}\text{O}_{42} (Sermorelin) / \text{C}_{45}\text{H}_{55}\text{N}_{9}\text{O}_{6} (GHRP-2)
Ā Purity Standard: Exceeds 99% (Third-Party HPLC Verified)
Ā Formulation: Sterile Lyophilized Powder
Ā Origin: Manufactured in USA
Ā Classification: Research Use Only
Primary Research Applications
Ā Dual-Mechanism GH Secretion Synergy: Combines GHRH receptor stimulation (Sermorelin) with ghrelin/growth hormone secretagogue receptor (GHS-R) binding (GHRP-2) to analyze supra-additive pituitary growth hormone pulsatility.
Ā Somatotropic Axis & IGF-1 Dynamics: Extensively evaluated in endocrine research models measuring downstream serum IGF-1 upregulation, nitrogen retention, and cellular protein synthesis signaling.
Ā Metabolic Rate & Lipid Oxidation: Investigated in body composition models to assess lipolysis mechanisms, visceral fat metabolism, and recovery dynamics following cellular stress.
